INDIVIDUAL VERSUS TECHNOLOGY Research, treatment and policy - ethical dilemmas Gabrielle Welle-Strand - Researcher, MD, Senior Adviser Pompidou Group –

Slides:



Advertisements
Similar presentations
Prison staff and harm reduction Additional module: Foreign prisoners Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable.
Advertisements

Service delivery and health care improvement in Georgia Thoughts from a recent case study Dr. Francoise Cluzeau Senior Adviser NICE International.
1 Off-Label Use of Medications in Workers Compensation Matthew Foster, PharmD, BCPS PMSI Clinical Services.
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Bellwork If you roll a die, what is the probability that you roll a 2 or an odd number? P(2 or odd) 2. Is this an example of mutually exclusive, overlapping,
Why is it different? Disease of the mind affecting understanding and mental ability of the human being - disorder of attention concentration cognition.
1 of 19 Organization and Management New Approaches to motivating Staff IMARK Investing in Information for Development Organization and Management New Approaches.
Department of Education Effective science education for innovation Robin Millar.
Building an EU consensus for minimum quality standards in the prevention, treatment and harm reduction of drugs Quality Standards - Policy Perspectives.
Background information
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD A report prepared by WHO for the Netherlands Government by Warren Kaplan Richard Laing and Saloni TannaMarjolein.
Instructions on Current Life- Sustaining Treatment Options Form: Objectives and Use Jack Schwartz Attorney Generals Office April 2008.
0 - 0.
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Addition Facts
1 Strategies to better safeguard children in highly diverse communities Research undertaken for Tower Hamlets LSCB.
Nina Dunham R&D Manager
Mixed methods synthesis ESRC Methods Festival 2006 James Thomas Institute of Education, University of London.
Implementing NICE guidance
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
REASONING WITH SUBJUNCTIVE (COUNTERFACTUAL) AND INDICATIVE CONDITIONALS A comparison of children, adolescents and adults Eva Rafetseder & Josef Perner.
O X Click on Number next to person for a question.
5.9 + = 10 a)3.6 b)4.1 c)5.3 Question 1: Good Answer!! Well Done!! = 10 Question 1:
Twenty Questions Subject: Twenty Questions
HORIZON 2020 STEPHEN FOX FOR KEELE UNIVERSITY 26 TH FEBRUARY 2014.
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
What place of importance does it hold in 21st century
Primary and secondary use of EHR: Enhancing clinical research Pharmaceutical Industry Perspectives Dr. Karin Heidenreich Senior Public Affairs Manager/Novartis.
Addition 1’s to 20.
Test B, 100 Subtraction Facts
11 = This is the fact family. You say: 8+3=11 and 3+8=11
Week 1.
1 Ke – Kitchen Elements Newport Ave. – Lot 13 Bethesda, MD.
Handling (and Preventing) Missing Data in RCTs ASENT March 7, 2009 Janet Wittes Statistics Collaborative.
O X Click on Number next to person for a question.
1 / 20 Crushing virtual cigarettes helps reducing tobacco addiction. Final results from a preliminary control trial Girard 1, B., Turcotte 1, V., & Bouchard.
What CQC do CQC are the health and social care regulator for England CQC register and monitor all health and social care providers in the country to ensure.
1. Choosing outcomes and measures - for doing and using research James Lind Alliance Outcomes in clinical research – whose responsibility? 20 November.
Research methodology & Ethical considerations
Difficulties to go back to work in case of common and chronic Low Back Pain Points of view of patients, of general practitioners and of National Health.
EBD for Dental Staff Seminar 1: Educational prescription, structured questions and effective searching Dominic Hurst evidenced.qm.
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Draft Ethical Guidelines Institute for Employment Studies Social Research Association.
How to Critically Review an Article
Reading Scientific Papers Shimae Soheilipour
Overview of operational research in MSF Myriam Henkens, MD, MPH International Medical Coordinator MSF London 1st of June, 2006.
OPIOID SUBSTITUTION THERAPY
Introduction Professor Christopher Hood Chair of the Working Party.
Evidence, guidelines and practice: the way forward in a digital age SYDNEY 11 April, 2013 Bill Runciman Professor – Patient Safety & Healthcare Human Factors.
Using the Biomedical Library & Its Resources: Becoming Efficient Information Managers BMD 201 Fall 2013.
Module 1 General introduction to substitution treatment.
1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory.
Applicability of principles Reidar K. Lie, MD, PhD Department of Clinical Bioethics, NIH and University of Bergen, Norway.
Identifying current and potential ethical challenges and Dilemmas in HIV prevention Research Ethics in clinical research: challenges linked.
Implementing a new drug or technique (APA Cambridge 21. June 2013) Tom G. Hansen, MD, PhD, Department of Anaesthesia & Intensive Care Odense University.
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
From bench to bedside on stem cell therapy for heart repair and vice versa: do we need a new consensus? John Martin British Heart Foundation Professor.
Collaboration and its outcomes in primary care compared internationally Sanneke Schepman Johan Hansen Ronald Batenburg Dinny de Bakker Netherlands Institute.
How Empty Are Empty Reviews? The first report on the Empty Reviews Project sponsored by the Cochrane Opportunities Fund and an invitation to participate.
How to Read a Journal Article. Basics Always question: – Does this apply to my clinical practice? – Will this change how I treat patients? – How could.
A quick reference to literature searches
6% of adults had used one or more illicit drugs in last 12 months.
8. Causality assessment:
Discontinuing Buprenorphine
The Moroccan Observatory on Drugs
The Research Question Background: Question:
Validity, Specificity, and Reliability Of Informed Consent
Presentation transcript:

INDIVIDUAL VERSUS TECHNOLOGY Research, treatment and policy - ethical dilemmas Gabrielle Welle-Strand - Researcher, MD, Senior Adviser Pompidou Group – Dubrovnik – October 1st 2008

| gws Oct 2008 | 2 RESEARCH ON DRUG ABUSE AND TREATMENT In general: Too little research on drug abuse treatment Primarily research on neuroscience and medications used in treatment It is a multidisciplinary field Much less research on psychological, social and other issues linked to drug use and treatment We need more research on psychosocial interventions We need more qualitative research

| gws Oct 2008 | 3 RANDOMISED CONTROLLED TRIALS Gold standard in medicine The process of inclusion and exclusion leaves out most of the patients Conclusions based on this type of research, are they relevant in the real world of treating drug dependent patients with somatic and psychiatric co-morbidity? RCTs – randomised, controlled, but irrelevant? (M.Gossop, Europad 2002)

| gws Oct 2008 | 4 EVIDENCE BASED GUIDELINES Norway: Presently 3 guideline processes Perform systematic reviews of the literature to get answer to our clinical questions Very few of our questions can be answered through the systematic reviews Design of studies to be included Inclusion and exclusion criteria The quality of the studies we find

| gws Oct 2008 | 5 ” All our science, measured against reality, is primitive and childlike – and yet it is the most precious thing we have ”. Albert Einstein

| gws Oct 2008 | 6 SYSTEMATIC REVIEW OF THE LITERATURE – Use of opioids in pregnancy 1104 hits Medline525 Embase280 PsycINFO183 Cinahl77 CENTRAL duplicates 786 abstracts 141 papers 106 excluded: Main reason: No control group, other populations, reviews, 644 irrelevant studies 35 papers included

| gws Oct 2008 | 7 Publication year and country

| gws Oct 2008 | 8 KNOWLEDGE BASE FOR GUIDELINES Users’ knowledge and experience Knowledge based on experience = experts Knowledge based recommendations Knowledge based on research = evidence context

| gws Oct 2008 | 9 ”Evidence-based practice is the integration of best research evidence with clinical expertise and patient values” American Psychological Association 2003

| gws Oct 2008 | 10 “ Not everything that counts can be counted. And not everything that can be counted counts. “ Albert Einstein

| gws Oct 2008 | 11 In God we trust; all others please bring your data

| gws Oct 2008 | 12 RESEARCH ON DRUG ABUSE AND TREATMENT IS IMPORTANT We presently lack a lot of knowledge needed to tailor the treatment to meet individual needs Carefully designed studies are needed to give us better understanding of the mechanisms Up to recently – most treatment: “One size fits all” Main ethical dilemma – most treatment (not only for drug users) is undertaken without being sufficiently based on research Treatment in any one country is based on tradition, beliefs, hope and influence from many different parties (including industry)

| gws Oct 2008 | 13 ETHICS CONCERNING RESEARCH ON VULNERABLE GROUPS Last summer there were many articles and a lot of debate in one of the main newspapers in Norway about research on drug users Are drug users able to sign informed consent? Is it ethical to give drug users treatment which usually has long waiting lists in a research setting? (is it voluntary?) What about placebo controlled trials? In one study – 5 opiate dependent patients died

| gws Oct 2008 | 14 DRUG USE TREATMENT Politicians/governmental bodies put limitations to drug treatment proven by research to efficient Drug users are treated different from other medical patients (moralistic views) Examples Limited number of patients to be treated Age limit to enter treatment Efficient treatment illegal Limits to medication dose level

| gws Oct 2008 | 15 RESEARCH TO PROVE THAT NATIONAL PRIORITIES ARE WRONG/UNETHICAL Substitution treatment in Norway – waiting list study – 12 week placebo controlled treatment with buprenorphine Substitution treatment in Norway – short term (9 months) buprenorphine – slowly tapering off The patients wanted to taper-off Alternative of continuing substitution treatment

| gws Oct 2008 | 16 RECENT NEUROBIOLOGICAL RESEARCH Gives interesting perspectives on possible treatment interventions New knowledge about how the drugs effect the human brain after short or longer term use Who are vulnerable to drug abuse? Imaging of the brain could be used To predict relapse To follow the “success” of treatment

| gws Oct 2008 | 17 QUESTIONS How is the research financed? How are the studies designed and the study- subjects recruited and taken care of? How are the results of the research presented by the researchers? How are the results of the research used by the people treating drug users? How are the results of the research used by the decision-makers?

| gws Oct 2008 | 18 IT IS HOW WE USE IT…… More research on drug use treatment (of any kind) is needed to give us necessary information on What kind of treatment is efficient What kind of treatment which does not work What kind of treatment is harmful Ethical awareness has to be high Amongst the researchers Amongst the professionals treating the patients Amongst decision-makers